MedTrace Logo

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

NCT06541652 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-08-05

No results posted yet for this study

Summary

The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational studies aimed at identifying new molecular, histological, circulating and radiological tumor biomarkers, potentially useful at every stage of diagnosis and prognostic or theranostic evaluation.

Conditions

  • Hepatocholangiocarcinoma
  • Fibrolamellar Carcinoma
  • Hepatic Epithelioid Hemangioendothelioma
  • Hepatoblastoma
  • Hepatic Neuroendocrine Carcinoma
  • Hepatic Carcinosarcomas
  • Hepatic Cystadenoma
  • Hepatic Leiomyosarcomas
  • Hepatic Angiosarcomas
  • Cholangiocarcinoma

Sponsors & Collaborators

  • Société Nationale Française de Gastroentérologie

    collaborator OTHER

  • Federation Francophone de Cancerologie Digestive

    lead OTHER

Principal Investigators

  • jean-charles nault, Pr · Federation Francophone de Cancerologie Digestive

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-26
Primary Completion
2026-02-28
Completion
2031-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06541652 on ClinicalTrials.gov